Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) said that an abstract on its iron deficiency treatment Accrufer has been accepted for presentation at the National Association of Nurse Practitioners in Women's Health 26th Annual Women's Healthcare Conference in San Diego at the end of this month.
NPWH is the leading membership organization for Women's Health Nurse Practitioners and all NPs who perform women's and gender-related healthcare.